In hospitalized patients with CHS during the hyperemesis phase, a “nothing by mouth” regimen and IV hydration are typically employed until symptoms improve. As recovery progresses, patients are initially given clear liquids and gradually advance to a regular diet as tolerated. drug addiction In patients treated at home, recommendations are emphasized to consume fluids containing glucose and electrolytes between vomiting episodes to ensure adequate hydration. CHS patients generally do not experience significant weight loss, as periods of regular oral intake often compensate for the days of vomiting.
What is the treatment for CHS?
- From sinus infections and high blood pressure to preventive screening, we’re here for you.
- The exact cause of Cannabinoid Hyperemesis Syndrome (CHS) is not fully understood.
- Patients must be informed that habitual cannabis use can result in cannabinoid accumulation in adipose tissue, leading to prolonged or recurrent symptoms that may take weeks to completely resolve.
- In some people, prolonged exposure to cannabis may disrupt this system, leading to symptoms like nausea and vomiting.
- Over time, these receptors may become overactive, leading to the severe nausea and vomiting experienced by people with CHS.
These phases can last different lengths of time, and not everyone’s experience is identical. If you or someone you know has reached a point of “scromiting,” it’s definitely time to consult a healthcare provider. When cannabis is the underlying cause, learning about CHS can be a life-changing discovery.
Hyperemetic Phase of CHS –
Over time, chronic cannabis use may change how these receptors respond, potentially leading to CHS symptoms. This article explains what scientists believe causes CHS, chs syndrome the different phases of the condition, and why diagnosis can be tricky. Importantly, we’ll cover treatment options to help you manage the symptoms and the crucial role of stopping cannabis use in achieving lasting relief. Cannabinoid Hyperemesis Syndrome (CHS) can have both immediate and long-term effects on health. Understanding the risk factors for CHS, such as long-term marijuana use, age, gender, and sociocultural background, can help in identifying individuals who are more likely to experience these effects and risks.
What Are the Treatment Options for CHS?
Cannabinoid hyperemesis syndrome (CHS) is a condition that sometimes develops due to the long term use of marijuana. While conventional antiemetic medications like serotonin 5-HT3 receptor antagonists and dopamine antagonists can be prescribed to manage nausea and vomiting in CHS patients, their efficacy in CHS cases is limited. These therapies may offer transient relief but are not comprehensive solutions for CHS symptomatology.
Therapies and Treatment Programs
The only treatment that can get rid of CHS symptoms for good is to stop using cannabis completely. But there are some other treatments that may help manage your symptoms and make you feel better. Severe and uncontrollable vomiting increases the risk of dehydration and electrolyte imbalances, and in rare cases, patients can experience esophageal tears, Camenga said. Doctors often treat CHS patients who seek help at hospitals with fluids.
Nausea and vomiting tend to return if they start using marijuana again. They also experience episodes of vomiting that return every few weeks or months. The first reports came from doctors treating regular users of marijuana for nausea and vomiting in South Australia. We also recommend that psychometric testing be examined to assess comorbidities of anxiety, depression and addiction potential that are suggested susceptibilities from prior study (Russo et al., 2022). Given logistical challenges in recruitment and retention, such an effort will require funding sources to mount multicenter studies. Cannabigerol (CBG) also inhibits FAAH (Bisogno et al., 2001) but has been reported in surveys to alleviate gastrointestinal symptoms including inflammatory bowel diseases (Russo et al., 2021).
People who use marijuana long-term — typically for about 10 to 12 years — are at risk of developing CHS. But not every person who uses marijuana, even long-term use, develops CHS. By Anna GiorgiGiorgi is a freelance writer with more than 25 years of experience writing health and wellness-related content.